Infection Control News and Research

RSS

Accelerating life science computing with AI-ready infrastructure

Discover how computing is transforming life science research through AI infrastructure, GPU acceleration, and genomics.

From Advantech 10 Aug 2026

Single-use endoscope aims to improve gastric cancer screening

Gastric cancer screening in Japan still relies heavily on double-contrast X-ray imaging, commonly known as the barium test.

9 Aug 2026

Long-acting HIV prevention tools could help close the gap before a vaccine arrives

A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, vertical transmission programs, and voluntary medical male circumcision. Gene editing and multispecific antibodies may expand future options, but safety, cost, access, adherence, and implementation barriers remain.

5 Aug 2026

Europe risks missing target to eliminate viral hepatitis by 2030

While Europe has made steady progress in preventing hepatitis B and C, with the prevalence of hepatitis B now at near-zero levels among children below five years old, an uneven implementation of key measures means that the region is set to miss the 2030 target to eliminate viral hepatitis as a public health threat, according to new data from the European Centre for Disease Prevention and Control (ECDC) on World Hepatitis Day.

28 Jul 2026

Rising antimicrobial resistance in children threatens life-saving antibiotic effectiveness

Antimicrobial resistance in children is rising globally and will worsen over the next decade, threatening the effectiveness of life‑saving antibiotics, according to a world-first monitoring platform.

20 Jul 2026

New portable strip test accurately detects mosquito-borne viruses

A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, portable detection of mosquito-borne viruses, using Chikungunya virus (CHIKV) as a model target.

17 Jul 2026

New battery-powered device detects Bundibugyo Ebola virus in thirty minutes

Professor Yasutoshi Kido of the Graduate School of Medicine, Osaka Metropolitan University (OMU), in collaboration with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) of the Democratic Republic of the Congo, is developing a portable rapid diagnostic system for Ebola virus disease (EVD) caused by Bundibugyo virus (BDBV).

17 Jul 2026

Robot-guided surgery successfully drains multiple deep brain abscesses

Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery. Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery.

13 Jul 2026

New bionic skin wound dressing accelerates infected tissue healing

Dressings face a critical limitation: no single product has successfully integrated protective function, wearing comfort, and efficient antibacterial activity.

11 Jul 2026

Memory B cells reveal how nasal vaccines could stop respiratory infections earlier

A Science Immunology Review explains how memory B cells acquire diverse molecular, epigenetic, and tissue-specific programs that shape long-term immune protection. It highlights lung-resident memory B cells as a key target for mucosal vaccines, potentially improving control of airborne infections and reducing transmission.

6 Jul 2026

Bionic cooling skin accelerates healing and combats wound infections

As the global burden of infected wounds continues to rise-with over 300 million surgeries performed annually and postoperative infections affecting 5–20% of patients-conventional wound dressings face a critical limitation: no single product has successfully integrated protective function, wearing comfort, and efficient antibacterial activity.

15 Jun 2026

Key proteins enable louse-borne relapsing fever pathogen to evade immunity

Louse-borne relapsing fever is caused by the spirochete bacterium Borrelia recurrentis, which is transmitted by body lice (not head lice).

10 Jun 2026

UK manufacturer supplying Ebola response warns infection-control readiness cannot wait for crisis

As health agencies respond to the current Ebola outbreak in Central Africa, a UK manufacturer supplying water purification products for direct distribution in affected communities is warning that infection-control readiness must be planned long before an emergency takes hold.

5 Jun 2026

How a tiny H5N1 dose triggers massive virus shedding in cow milk

Experimental infection studies in lactating Holstein cows showed that H5N1 B3.13 can infect the bovine mammary gland at doses as low as 10 TCID50, producing extremely high viral loads in milk. However, the virus did not transmit to sentinel cows through repeated exposure to contaminated milking equipment or through close contact under high-biocontainment conditions, suggesting that real-world dairy-farm spread depends on additional cofactors.

25 May 2026

Hantavirus scare on cruise ship prompts WHO response

Hantavirus infections among cruise ship passengers have sparked a global health response, highlighting the need for effective outbreak management strategies.

7 May 2026

New coating prevents protein adhesion to reduce hospital infections

A non-toxic coating developed by researchers at University of Toronto Engineering prevents proteins from sticking to surfaces - potentially offering a new tool in the fight against hospital-acquired infections.

5 May 2026

Photodynamic strategies enhance antibacterial performance of titanium orthopedic implants

The increasing global aging population has led to a steady rise in the demand for titanium orthopedic implants.

5 May 2026

Bacterial vesicles emerge as powerful tools against antibiotic resistance

Antibiotic resistance is making bacterial infections harder to treat, demanding new therapeutic strategies. A new review highlights bacterial extracellular vesicles (BEVs) as promising nanoscale tools that can kill pathogens, block infection, enhance vaccines, and deliver drugs.

25 Apr 2026

Simple oral care cuts hospital-acquired pneumonia risk

A landmark trial presented today at ESCMID Global 2026 shows that improving oral hygiene for hospital patients can reduce the risk of non-ventilator-associated hospital-acquired pneumonia (NV-HAP) by 60%.

20 Apr 2026